Royal UNIBREW A/S
16.3.2026 13:59:32 CET | Globenewswire | Press release
Transactions by persons discharging managerial responsibilities and/or persons closely associated
Transactions by persons discharging managerial responsibilities and/or persons closely associated
COMPANY ANNOUNCEMENT NO 8/2026 - March 16, 2026
Royal Unibrew A/S hereby makes public pursuant to article 19(3) of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse the information on the below transaction related to shares in Royal Unibrew A/S made by persons discharging managerial responsibilities in Royal Unibrew A/S and/or persons closely related with them.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Kalle Järvinen | |
| 2 | Reason for the notification | ||
| a) | Position/status | SVP General Manager, Finland, Royal Unibrew A/S | |
| b) | Initial notification / Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Royal Unibrew A/S | |
| b) | LEI | 529900D69KFL8IAP8Q63 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares in Royal Unibrew A/S ISIN DK0060634707 | |
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 583 | 600 | ||
| d) | Aggregated information
| 600 EUR 46,589.34 (DKK 349,800.00) | |
| e) | Date of the transaction | 2026-03-10, 09:00:00 CET | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S. MIC code is DCSE. Operating MIC code is XCSE. | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Kalle Järvinen | |
| 2 | Reason for the notification | ||
| a) | Position/status | SVP General Manager, Finland, Royal Unibrew A/S | |
| b) | Initial notification / Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Royal Unibrew A/S | |
| b) | LEI | 529900D69KFL8IAP8Q63 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares in Royal Unibrew A/S ISIN DK0060634707 | |
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 576.3379 | 700 | ||
| d) | Aggregated information
| 700 EUR 53,858.92 (DKK 403,436.53) | |
| e) | Date of the transaction | 2026-03-11, 16:51:17 CET | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S. MIC code is DCSE. Operating MIC code is XCSE. | |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom